Evidence map›Paper›PMID 35361626›Full record

ArticleGenome research2022

Variations in antibody repertoires correlate with vaccine responses.

Yana Safonova, Sung Bong Shin, Luke Kramer, James Reecy, Corey T Watson, Timothy P L Smith, Pavel A Pevzner

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yana SafonovaComputer Science and Engineering Department, University of California at San Diego, San Diego, California 92093, USA.ORCID 0000-0002-9634-4216
Sung Bong ShinU.S. Meat Animal Research Center, USDA-ARS, Clay Center, Nebraska 68933, USA.
Luke KramerDepartment of Animal Science, Iowa State University, Ames, Iowa 50011, USA.
James ReecyDepartment of Animal Science, Iowa State University, Ames, Iowa 50011, USA.
Corey T WatsonDepartment of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA.
Timothy P L SmithU.S. Meat Animal Research Center, USDA-ARS, Clay Center, Nebraska 68933, USA.
Pavel A PevznerComputer Science and Engineering Department, University of California at San Diego, San Diego, California 92093, USA.
Iowa State University · USRoman L. Hruska U.S. Meat Animal Research Center · USUniversity of Louisville · USUniversity of San Diego · US

Funding

TrainingP41GM103484 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BANDEIRA, NUNO · 2012 to 2018
$8.7M
Population level characterization of human immunoglobulin heavy chain germline variants with impacts on variability in the Ab repertoire of healthy adultsR21AI142590 · NIAID · UNIVERSITY OF LOUISVILLE · PI MARASCO, WAYNE A., WATSON, COREY TAYLOR · 2019 to 2020
$477k
NIAID NIH HHS R21 AI142590NIGMS NIH HHS P41 GM103484
6 · The paper itself

Abstract

An important challenge in vaccine development is to figure out why a vaccine succeeds in some individuals and fails in others. Although antibody repertoires hold the key to answering this question, there have been very few personalized immunogenomics studies so far aimed at revealing how variations in immunoglobulin genes affect a vaccine response. We conducted an immunosequencing study of 204 calves vaccinated against bovine respiratory disease (BRD) with the goal to reveal variations in immunoglobulin genes and somatic hypermutations that impact the efficacy of vaccine response. Our study represents the largest longitudinal personalized immunogenomics study reported to date across all species, including humans. To analyze the generated data set, we developed an algorithm for identifying variations of the immunoglobulin genes (as well as frequent somatic hypermutations) that affect various features of the antibody repertoire and titers of neutralizing antibodies. In contrast to relatively short human antibodies, cattle have a large fraction of ultralong antibodies that have opened new therapeutic opportunities. Our study reveals that ultralong antibodies are a key component of the immune response against the costliest disease of beef cattle in North America. The detected variants of the cattle immunoglobulin genes, which are implicated in the success/failure of the BRD vaccine, have the potential to direct the selection of individual cattle for ongoing breeding programs.

Indexed as

Cattle DiseasesVaccinesAnimalsAntibodiesCattleNorth AmericaAntibodiesVaccines

Identifiers

PMID35361626
PMCPMC8997358
OpenAlexW4220885376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.